HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
WIRION Embolic Protection System – 1st Patients Treated Reports Cardiovascular Systems, Inc.
WIRION Embolic Protection System is a distal embolic protection filter used to capture thrombus and debris that can be associated with all types of peripheral vascular intervention procedures, including atherectomy.
Zenith Award from American Association for Respiratory Care for Support of Respiratory Therapists Is Awarded to Vapotherm
Award celebrates excellence in support and quality as chosen by AARC member votes
Accelus Introduces LineSider Modular-Cortical System for Posterior Fixation
Accelus notes designed for greater procedural visibility, versatility and efficiency, the modular screw design provides surgeons with enhanced visualization by allowing the placement of screw shanks early in the procedure, followed by modular tulips and rods at the end.
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in...
The precision and accuracy enabled by the system's robotic design will also make it an ideal choice for the treatment of neurologic disorders. The new system will enable the medical team to deliver gold standard stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments faster than with previous models, expanding access to an effective and convenient option to more patients.
UroCure Expands SUI Sling Portfolio with the Nationwide Launch of the ArcSP and ArcTO Slings
These two additions complement the current UroCure ArcTV® Transvaginal Sling on the market.
Medtronic Diabetes REPORTS World’s 1st Approval for MiniMed™ 780G System with Simplera Sync™ Disposable, All-in-one Sensor
Que Dallara, EVP and President, Medtronic Diabetes comments....
"We're incredibly proud that the MiniMed™ 780G system continues to be the most widely used automated insulin delivery system in Europe since we launched it in 2020. Real-world data on over 100,000 users on the system across many geographies and cultures shows that when using recommended settings the system is delivering an average Time in Range of nearly 80%, raising the bar on what 'good' looks like."
Medtronic Receives CE Mark for its Next Generation Micra Leadless Pacing Systems
Micra AV2 and Micra VR2, the world's smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing such as reduced complications compared to traditional pacemakers reports Medtronic.
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
The LOI expresses the mutual interest by both parties to further explore potential collaboration regarding the evaluation of how the INSPIRA ART100 device ("Device" or "Devices") aligns with Northwestern's needs in clinical scenarios, workflow efficiency, and healthcare delivery.
HR Pharmaceuticals Receives Exclusive Commercialization Rights to Poiesis Medical’s Dual Balloon Catheter Technology in No America
The Dual Balloon Catheter has demonstrated significant benefits compared to traditional Foley catheters, leading to better patient outcomes. Specifically, we see a great opportunity for patients requiring indwelling catheterization greater than five days. This product will become an important part of our broader urology strategy over the next 12 months," states Colby Wiesman, President of HR Pharmaceuticals, Inc.
